48,830
edits
Difference between revisions of "Peripheral nerve sheath tumours"
Jump to navigation
Jump to search
m
Peripheral nerve sheath tumours (view source)
Revision as of 16:57, 1 June 2012
, 16:57, 1 June 2012→Malignant triton tumour
(→Malignant triton tumour: expand... add IHC, EM) |
|||
| Line 321: | Line 321: | ||
*Prognosis worse that conventional MPNST.<ref name=pmid17149968/> | *Prognosis worse that conventional MPNST.<ref name=pmid17149968/> | ||
**Five year survival ~14%.<ref name=pmid22253011>{{Cite journal | last1 = McConnell | first1 = YJ. | last2 = Giacomantonio | first2 = CA. | title = Malignant triton tumors-complete surgical resection and adjuvant radiotherapy associated with improved survival. | journal = J Surg Oncol | volume = | issue = | pages = | month = Jan | year = 2012 | doi = 10.1002/jso.23042 | PMID = 22253011 }}</ref> | **Five year survival ~14%.<ref name=pmid22253011>{{Cite journal | last1 = McConnell | first1 = YJ. | last2 = Giacomantonio | first2 = CA. | title = Malignant triton tumors-complete surgical resection and adjuvant radiotherapy associated with improved survival. | journal = J Surg Oncol | volume = | issue = | pages = | month = Jan | year = 2012 | doi = 10.1002/jso.23042 | PMID = 22253011 }}</ref> | ||
*Diagnosis may require clinical information, i.e. individual has a history of [[neurofibromatosis type 1]]. | *Diagnosis may require clinical information, i.e. individual has a history of [[neurofibromatosis type 1]] (NF1). | ||
Note: | Note: | ||
| Line 331: | Line 331: | ||
# Schwann cell tumour characteristics. | # Schwann cell tumour characteristics. | ||
# Rhabdomyoblasts. | # Rhabdomyoblasts. | ||
#* | #* Eccentric nucleus. | ||
#* Moderate amount of eosinophilic cytoplasm. | |||
#* +/-Cross-striations. | #* +/-Cross-striations. | ||
| Line 338: | Line 339: | ||
*[[Adult fibrosarcoma]]. | *[[Adult fibrosarcoma]]. | ||
*[[Synovial sarcoma]]. | *[[Synovial sarcoma]]. | ||
*[[Rhabdomyosarcoma]]. | |||
*[[Carcinosarcoma]]. | |||
===IHC=== | ===IHC=== | ||